S. Sonoke

发表

Comparison of LNS-AmB, a novel low-dose formulation of amphotericin B with lipid nano-sphere (LNS), with commercial lipid-based formulations.

H. Fukui, T. Koike, T. Nakagawa, 2003, International journal of pharmaceutics.

A novel delivery system for amphotericin B with lipid nano-sphere (LNS).

H. Fukui, T. Koike, A. Saheki, 2003, International journal of pharmaceutics.

Decreased binding affinity of apolipoprotein C-II to Lipid Nano-Sphere (LNS) plays an important role in the plasma half-life and reduced hæmolytic activity

T. Mayumi, H. Fukui, A. Saheki, 2004 .

A nanometer lipid emulsion, lipid nano-sphere (LNS), as a parenteral drug carrier for passive drug targeting.

T. Mayumi, H. Sasaki, H. Fukui, 2004, International journal of pharmaceutics.

Liver target delivery of small interfering RNA to the HCV gene by lactosylated cationic liposome.

M. Kohara, J. Yano, T. Ohgi, 2007, Journal of hepatology.

Decreased binding affinity of apolipoprotein E plays an important role in the reduced hepatic clearance of Lipid Nano-Sphere (LNS)

T. Mayumi, H. Fukui, A. Saheki, 2004 .

Steviol and steviol-glycoside: glucosyltransferase activities in Stevia rebaudiana Bertoni--purification and partial characterization.

M. Yoshioka, H. Shibata, Y. Sawa, 1995, Archives of biochemistry and biophysics.

Glucosylation of Steviol and Steviol-Glucosides in Extracts from Stevia rebaudiana Bertoni.

H. Shibata, M. Yamada, S. Sonoke, 1991, Plant physiology.

Evaluation of the efficacy and toxicity of amphotericin B incorporated in lipid nano-sphere (LNS).

H. Fukui, T. Koike, A. Saheki, 2003, International journal of pharmaceutics.

In Vitro and In Vivo Activities of NS-718, a New Lipid Nanosphere Incorporating Amphotericin B, againstAspergillus fumigatus

S. Kohno, K. Tomono, M. A. Hossain, 1999, Antimicrobial Agents and Chemotherapy.

Galactose-modified cationic liposomes as a liver-targeting delivery system for small interfering RNA.

J. Yano, T. Ueda, S. Sonoke, 2011, Biological & pharmaceutical bulletin.

Tumor regression in mice by delivery of Bcl-2 small interfering RNA with pegylated cationic liposomes.

K. Hirabayashi, J. Yano, T. Ohgi, 2008, Cancer research.

Therapeutic effects of microRNA-582-5p and -3p on the inhibition of bladder cancer progression.

N. Kosaka, T. Ochiya, F. Takeshita, 2013, Molecular therapy : the journal of the American Society of Gene Therapy.

Lipid transfer protein transports compounds from lipid nanoparticles to plasma lipoproteins.

T. Mayumi, H. Fukui, T. Koike, 2004, International journal of pharmaceutics.

Lipid nano-sphere(LNS), a protein-free analogue of lipoproteins, as a novel drug carrier for parenteral administration. IV.

H. Sasaki, H. Fukui, M. Sugiyama, 1994 .